Swiss drug giant Novartis has announced the launch of two new joint working projects with national Cancer Vanguard sites, which aim to determine novel ways of boosting patient care pathways and access to services.
Read More
The Cancer Vanguard and Amgen have developed a simulation modelling tool to show health commissioners and trusts the financial benefits and challenges of delivering breast cancer medicines in a variety of community settings.
Read More
The NHS’ Cancer Vanguard is partnering with Amgen and Sandoz to improve the provision of cancer medicines to NHS patients.
Read More
